MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Changes in gait and mobility measures collected in daily living conditions, in different stages of Parkinson’s disease

N. Geffen, K. Cohavi, N. Giladi, A. Thaler, R. Alcalay, J. Edgerton, J. Shirvan, J. Cedarbaum, J. Hausdorff, A. Mirelman (Tel Aviv, Israel)

Meeting: 2022 International Congress

Abstract Number: 364

Keywords: Gait disorders: Clinical features, Parkinson’s

Category: Technology

Objective: To explore mobility measures collected in daily-living conditions in different stages of PD.

Background: Gait and mobility impairments are considered a cardinal sign in Parkinson’s disease (PD), gradually deteriorating as the disease progresses and severely impacting independence and quality of life. However, mobility assessment is usually done in a controlled clinical environment and little is known on the patterns of movement in everyday life and their progression with disease.

Method: The study used a cross-sectional design to compare between healthy controls (HC) and patients with PD divided into three groups based on their “Hoehn and Yahr” (H&Y) score. Mobility data was collected using a tri-axial accelerometer (AX3, Axivity) worn by patients on the lower back for 7 days. Signals were analyzed using a wavelet based algorithm. Gait epochs and Sit-to-Stand (StS) transitions were detected. Measures extracted for the postural transitions included the number of transitions-per-day, transition duration, jerk, vertical velocity, and acceleration range. Gait measures included step count, number of walking bouts (NoB), percent-of-activity (PoA) and mean SVM per day. Mobility data was supplemented by a thorough neurological assessment. Age, gender, and disease severity were included as co-variates in the analysis.

Results: 141 HC (mean age 53.0±10.2yrs), 63 early stage (ES)-PD (60.9±10.7yrs; H&Y: 1.1±0.2), 136 mild-PD (66.3 ± 9.2; H&Y: 2.0±0.1) and 44 moderate-PD (79.3 ± 6.9; H&Y: 2.87 ± 0.2) were compared. Step count, NoB, PoA, and mean SVM were not different between HC and ES-PD but showed a significant gradual decline between the PD groups. Similarly, the number of daily transitions declined with disease severity. However, transition “quality” measures such as jerk, vertical velocity and range only differed between HC and ES-PD but not between the PD groups.

Conclusion: Daily living activity collected by an accelerometer may provide useful insights into disease progression. With disease progression, transition quantity and changes in gait becomes more pronounced. Postural transitions quality measures may be sensitive indicators for PD more than activity and gait measures.

To cite this abstract in AMA style:

N. Geffen, K. Cohavi, N. Giladi, A. Thaler, R. Alcalay, J. Edgerton, J. Shirvan, J. Cedarbaum, J. Hausdorff, A. Mirelman. Changes in gait and mobility measures collected in daily living conditions, in different stages of Parkinson’s disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/changes-in-gait-and-mobility-measures-collected-in-daily-living-conditions-in-different-stages-of-parkinsons-disease/. Accessed May 16, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/changes-in-gait-and-mobility-measures-collected-in-daily-living-conditions-in-different-stages-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley